Erkan Baloglu, Stoneham, MA (US); Sharon Shacham, Newton, MA (US); Dilara McCauley, Arlington, MA (US); Trinayan Kashyap, Framingham, MA (US); William Senapedis, Millis, MA (US); Yosef Landesman, Brookline, MA (US); Gali Golan, Mesilat Zion (IL); Ori Kalid, Pardes Hanna (IL); and Sharon Shechter, Andover, MA (US)
Assigned to Karyopharm Therapeutics Inc., Newton, MA (US)
Filed by Karyopharm Therapeutics Inc., Newton, MA (US)
Filed on Aug. 23, 2021, as Appl. No. 17/409,150.
Application 17/409,150 is a continuation of application No. 16/519,955, filed on Jul. 23, 2019, granted, now 11,124,493.
Application 16/519,955 is a continuation of application No. 15/651,856, filed on Jul. 17, 2017, granted, now 10,407,405, issued on Sep. 10, 2019.
Application 15/651,856 is a continuation of application No. 14/900,469, granted, now 9,738,624, issued on Aug. 22, 2017, previously published as PCT/US2014/043479, filed on Jun. 20, 2014.
Claims priority of provisional application 61/838,172, filed on Jun. 21, 2013.
Prior Publication US 2022/0177445 A1, Jun. 9, 2022